Vidac Pharma Receives Notice of Issuance from USPTO for One of Its Core Patents
London, UK – Vidac Pharma Holdings Plc. (XETRA: T9G | ISIN: GB00BM9XQ619 | WKN: A3DTUQ) announces that it has received a Notice of Issuance from the United States Patent and…